Z-2319-2017 Class II Ongoing
FDA device recall Z-2319-2017 was initiated by Nexstim PLC on Mar 14, 2017 and is designated Class II. Reason for recall: Software defect: the NBS software may accidentally generate duplicate copies of one or several files. The recall status is ongoing. Affected quantity: 11 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 14, 2017
- Initiation Date
- Mar 14, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11 units.
Product description
Nexstim eXima NBS System Software version 2.2 or higher. The Nexstim Navigated Brain Stimulation System (NBS System) is indicated for noninvasive mapping of the primary motor cortex of the brain to its cortical gyrus. The NBS System provides information that may be used in the assessment of the primary motor cortex for pre-procedural planning. The NBS System is not intended to be used during a surgical procedure. The NBS System is intended to be used by trained clinical professionals.
Reason for recall
Software defect: the NBS software may accidentally generate duplicate copies of one or several files.
Distribution pattern
Worldwide Distribution - US to GA only, Foreign: Europe
Code information
Serial numbers: NBS101, NBS106, NBS140, NBS141, NBS145, NBS148, NBS155, NBS159, NBS163, NBS164, NBS166. NBS158 has been scrapped.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2319-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Nexstim PLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.